Forward to a friend |
Subscribe | The Record Archive | Contacts | bcbsm.com | Print this article
|
January 2025
Commercial prior authorization requests submitted through NovoLogix must be submitted through a different application, starting April 1For most commercial members, health care providers will need to submit prior authorization requests for medical benefit drugs that are currently submitted through the NovoLogix® online tool through a different application. This applies to dates of service on or after April 1, 2025. Blue Cross Blue Shield of Michigan and Blue Care Network will continue to manage the prior authorization and site-of-care requirements for these drugs. Through March 31, 2025, continue to submit these prior authorization requests through NovoLogix. This includes requests involving site-of-care requirements. Watch for additional communications about training opportunities and resources for the application in first-quarter 2025. NovoLogix is an independent company that provides an online prescription drug prior authorization tool for Blue Cross Blue Shield of Michigan and Blue Care Network. |
|
No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.
|